New report estimates nearly 18 million cancer survivors in the US by 2022
- Details
- Category: Research
The number of Americans with a history of cancer, currently estimated to be 13.7 million, will grow to almost 18 million by 2022, according to a first-ever report by the American Cancer Society in collaboration with the National Cancer Institute (NCI).
The challenges and opportunities of clinical trials in developing countries
- Details
- Category: Research
Conducting more clinical trials in developing countries is of benefit because these populations are underrepresented in research, but doing trials in resource poor settings has many challenges. Research sites in developing countries benefit from working with externally sponsored clinical trials including increased capacity development and investment, but locally led research is also challenged by complex trial regulations and administrative burdens.
Statins shown to cause fatigue
- Details
- Category: Research
In a study of more than 1,000 adults, researchers at the University of California, San Diego, found that individuals taking cholesterol-lowering statin drugs are more likely than non-users to experience decreased energy, fatigue upon exertion, or both.
Researchers develop a 'time bomb' to fight cardiovascular disease
- Details
- Category: Research
In Switzerland, more than 20,000 people (37% of all deaths) die of cardiovascular disease caused by atherosclerosis each year. Treatment options are currently available to people who suffer from the disease but no drug can target solely the diseased areas, often leading to generalized side effects.
Alzheimer's vaccine trial a success
- Details
- Category: Research
A study led by Karolinska Institutet reports for the first time the positive effects of an active vaccine against Alzheimer's disease. The new vaccine, CAD106, can prove a breakthrough in the search for a cure for this seriously debilitating dementia disease. The study is published in the distinguished scientific journal Lancet Neurology.
New immune therapy shows promise in kidney cancer
- Details
- Category: Research
An antibody that helps a person's own immune system battle cancer cells shows increasing promise in reducing tumors in patients with advanced kidney cancer, according to researchers at Beth Israel Deaconess Medical Center.
Carfilzomib demonstrates efficacy as new frontline treatment regimen for multiple myeloma
- Details
- Category: Research
Results from a study published online in Blood, the Journal of the American Society of Hematology (ASH), demonstrate that inclusion of carfilzomib, a novel targeted therapy for multiple myeloma, in combination with lenalidomide and low-dose dexamethasone, resulted in complete or near complete remission in a majority of patients with newly diagnosed multiple myeloma.
More Pharma News ...
- New research yields insights into Parkinson's disease
- Thioridazine, successfully kills cancer stem cells in the human
- Calcium supplements linked to significantly increased heart attack risk
- Biomarker predicts response to cancer treatment
- In drug-approval race, US FDA ahead of Canada, Europe
- Blood pressure drugs don't protect against colorectal cancer
- Vitamin K2: New hope for Parkinson's patients?